Raymond James analyst John Ransom downgrades Cigna (NYSE:CI) from Strong Buy to Outperform and announces $370 price target.
TransAlta Corporation Enters Into Automatic Share Purchase Plan Under The Company’s Previously Announced Normal Course Issuer Bid
TransAlta Corporation ("TransAlta" or the "Company") (TSX:TA) (NYSE:TAC) announced today that it has entered into an automatic share purchase plan ("ASPP") with its broker in order to facilitate repurchases of
